Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | ASAH1 | Q13510 | 9/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9551083 | 0.86 | IDO1 (0.56) | IDO1ALDH1A1MAPTHSD17B10ASAH1 | |
| SCHEMBL7593679 | 0.83 | IDO1 (0.54) | IDO1ALDH1A1MAPTHSD17B10ASAH1 | |
| SCHEMBL17201488 | 0.83 | IDO1 (0.54) | IDO1ALDH1A1MAPTHSD17B10ASAH1 | |
| SCHEMBL5503210 | 0.80 | IDO1 (0.50) | IDO1ALDH1A1MAPTHSD17B10ASAH1 | |
| SCHEMBL5503209 | 0.80 | IDO1 (0.50) | IDO1ALDH1A1MAPTHSD17B10ASAH1 | |
| SCHEMBL5504041 | 0.80 | IDO1 (0.50) | IDO1ALDH1A1MAPTHSD17B10ASAH1 | |
| SCHEMBL5500883 | 0.80 | IDO1 (0.50) | IDO1ALDH1A1MAPTHSD17B10ASAH1 | |
| SCHEMBL5495838 | 0.80 | IDO1 (0.54) | IDO1ALDH1A1MAPTHSD17B10ASAH1 | |
| SCHEMBL5495840 | 0.80 | IDO1 (0.54) | IDO1ALDH1A1MAPTHSD17B10ASAH1 | |
| SCHEMBL5500885 | 0.80 | IDO1 (0.50) | IDO1ALDH1A1MAPTHSD17B10ASAH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008090046-A1 | ALTERNATE PROCESS FOR PREPARING 3,5-DI-OMICRON-ACYL-2-FLUORO-2-C-METHYL-D-RIBONO-GAMMA-LACTONE | F. HOFFMANN-LA ROCHE AG (CH) | 2008-07-31 | — | — | WO | claimed |
| US-20080177079-A1 | NOVEL PROCESS FOR THE PREPARATION OF (2R)-2-DEOXY-2-FLUORO-2-METHYL-D-ERYTHRO-PENTONO-GAMMA-LACTONE AND (2S)-2-DEOXY-2-FLUORO-2-METHYL-D-ERYTHRO-PENTONO-GAMMA-LACTONE | ROCHE CAROLINA INC. | 2008-07-24 | — | — | US | claimed |
| WO-2008090046-A1 | ALTERNATE PROCESS FOR PREPARING 3,5-DI-OMICRON-ACYL-2-FLUORO-2-C-METHYL-D-RIBONO-GAMMA-LACTONE | F. HOFFMANN-LA ROCHE AG (CH) | 2008-07-31 | — | — | WO | disclosed |
| WO-2008090046-A1 | ALTERNATE PROCESS FOR PREPARING 3,5-DI-OMICRON-ACYL-2-FLUORO-2-C-METHYL-D-RIBONO-GAMMA-LACTONE | F. HOFFMANN-LA ROCHE AG (CH) | 2008-07-31 | — | — | WO | disclosed |
| US-20080177079-A1 | NOVEL PROCESS FOR THE PREPARATION OF (2R)-2-DEOXY-2-FLUORO-2-METHYL-D-ERYTHRO-PENTONO-GAMMA-LACTONE AND (2S)-2-DEOXY-2-FLUORO-2-METHYL-D-ERYTHRO-PENTONO-GAMMA-LACTONE | ROCHE CAROLINA INC. | 2008-07-24 | — | — | US | disclosed |
| US-20080177079-A1 | NOVEL PROCESS FOR THE PREPARATION OF (2R)-2-DEOXY-2-FLUORO-2-METHYL-D-ERYTHRO-PENTONO-GAMMA-LACTONE AND (2S)-2-DEOXY-2-FLUORO-2-METHYL-D-ERYTHRO-PENTONO-GAMMA-LACTONE | ROCHE CAROLINA INC. | 2008-07-24 | — | — | US | disclosed |
| US-20080177079-A1 | NOVEL PROCESS FOR THE PREPARATION OF (2R)-2-DEOXY-2-FLUORO-2-METHYL-D-ERYTHRO-PENTONO-GAMMA-LACTONE AND (2S)-2-DEOXY-2-FLUORO-2-METHYL-D-ERYTHRO-PENTONO-GAMMA-LACTONE | ROCHE CAROLINA INC. | 2008-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080177079-A1 | NOVEL PROCESS FOR THE PREPARATION OF (2R)-2-DEOXY-2-FLUORO-2-METHYL-D-ERYTHRO-PENTONO-GAMMA-LACTONE AND (2S)-2-DEOXY-2-FLUORO-2-METHYL-D-ERYTHRO-PENTONO-GAMMA-LACTONE | FBL, NSUN2, RNGTT | IDO1 4262/4885ALDH1A1 1583/4885MAPT 4611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.